Modifying the Disease Course More than a dozen disease modifying therapies are approved by the U.S. Food and Drug Administration (FDA) for use in relapsing forms of MS, which include clinically isolated syndrome, relapsing-remitting disease (RRMS) and active secondary progressive disease (SPMS with relapses). Individuals who have been on one of these medications during the initial relapsing-remitting phase of the disease will likely continue on it unless it is no longer adequately controlling their disease activity. Read more about these therapies in The MS Disease-Modifying Medications (.pdf). Read more about starting, stopping or switching medications in the American Academy of Neurology Guideline: Disease Modifying Therapies for Adults with Multiple Sclerosis.
Managing symptoms Regardless of the course of MS a person is experiencing, proactive symptom management is essential to maintaining comfort and productivity, and enhancing quality of life.
Rehabilitation Rehabilitation specialists have an important role from the time of diagnosis helping people function optimally in spite of their MS, including enhancing mobility and promoting safety and independence.
Healthy Living Health and wellness, including emotional well-being, can be achieved even in the presence of a chronic illness or disability.
Need More Information? We Are Here Our MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or contact us online. Contact an MS Navigator Contact an MS Navigator
Newly Diagnosed If you or somone close to you has recently been diagnosed, access our MS information and resources. Start Here Start Here